TOI · Categories · Form 4

TOI - SEC Form 4 insider transactions

The Oncology Institute Inc. (TOI) sec form 4 insider transactions - real-time wire coverage filtered to Form 4 only.

Recent Form 4 for TOI

• 20m
  Chief Medical Officer Podnos Yale sold $126,094 worth of shares (23,451 units at $5.38) as part of a pre-agreed trading plan, decreasing direct ownership by 8% to 259,527 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 18d
  Chief Medical Officer Podnos Yale disposed of $8,068 worth of shares (1,805 units at $4.47), decreasing direct ownership by 0.63% to 282,978 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 18d
  Chief Executive Officer Virnich Daniel disposed of $103,069 worth of shares (23,058 units at $4.47), decreasing direct ownership by 0.98% to 2,337,166 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 18d
  Chief Financial Officer Carter Robert Ross disposed of $7,170 worth of shares (1,604 units at $4.47), decreasing direct ownership by 0.39% to 414,801 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 46d
  SEC Form 4 filed by Chief Administrative Officer England Kristin

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 46d
  SEC Form 4 filed by Chief Clinical Officer Langsam Jeffrey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 53d
  SEC Form 4 filed by Kaushal Mohit

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 57d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 68d
  SEC Form 4 filed by Langsam Jeffrey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 68d
  SEC Form 4 filed by England Kristin

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 68d
  SEC Form 4 filed by Podnos Yale

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 68d
  SEC Form 4 filed by Carter Robert Ross

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 68d
  SEC Form 4 filed by Virnich Daniel

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 71d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 74d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 76d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 78d
  SEC Form 4 filed by Chernett Jorey

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 83d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 83d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 83d
  SEC Form 4 filed by The Oncology Institute Inc.

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 154d
  Amendment: Chief Financial Officer Carter Robert Ross disposed of $895 worth of shares (244 units at $3.67), decreasing direct ownership by 0.10% to 235,125 units (SEC Form 4)

  4/A - Oncology Institute, Inc. (0001799191) (Issuer)
• 155d
  Chief Financial Officer Carter Robert Ross sold $879 worth of shares (247 units at $3.56), decreasing direct ownership by 0.10% to 235,122 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 175d
  Director Hively Brad sold $50,291 worth of shares (13,333 units at $3.77), decreasing direct ownership by 2% to 683,721 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 190d
  SEC Form 4 filed by Director Ling Gabriel

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Mcgeorge Anne was granted 108,024 shares, increasing direct ownership by 59% to 291,370 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Kaushal Mohit was granted 91,049 shares, increasing direct ownership by 51% to 268,302 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Ling Gabriel was granted 83,333 shares, increasing direct ownership by 33% to 333,539 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Johnson Karen Marie was granted 84,877 shares, increasing direct ownership by 42% to 288,286 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Pacala Mark L was granted 81,790 shares, increasing direct ownership by 47% to 256,761 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 197d
  Director Hively Brad was granted 74,074 shares, increasing direct ownership by 12% to 697,054 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 201d
  Director Pacala Mark L sold $200,000 worth of shares (50,000 units at $4.00), decreasing direct ownership by 22% to 174,971 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 201d
  Director M33 Growth I L.P. disposed of 3,090,892 shares and acquired 11,818 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 201d
  Director Ling Gabriel acquired 141,149 shares, increasing direct ownership by 129% to 250,206 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 202d
  Chief Executive Officer Virnich Daniel was granted 6,464 shares, increasing direct ownership by 0.36% to 1,799,984 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 202d
  Chief Medical Officer Podnos Yale was granted 2,086 shares, increasing direct ownership by 0.88% to 237,930 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 202d
  Chief Financial Officer Carter Robert Ross was granted 195 shares, increasing direct ownership by 0.08% to 235,369 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 207d
  Chief Medical Officer Podnos Yale was granted 1,508 shares, increasing direct ownership by 0.64% to 235,844 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 207d
  Chief Executive Officer Virnich Daniel was granted 6,211 shares, increasing direct ownership by 0.35% to 1,793,520 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 277d
  Director M33 Growth I L.P. sold $20,703,000 worth of shares (6,700,000 units at $3.09) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 292d
  Director Hively Brad sold $82,097 worth of shares (20,221 units at $4.06), decreasing direct ownership by 3% to 622,980 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 299d
  SEC Form 4 filed by Director Barasch Richard A

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 315d
  Director Barasch Richard A disposed of 287,756 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 319d
  Chief Administrative Officer England Kristin was granted 98,037 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 350d
  Director Barasch Richard A exercised 679,224 in-the-money shares at a strike of $1.20 and covered exercise/tax liability with 311,128 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 353d
  Director Barasch Richard A converted options into 779,900 shares, increasing direct ownership by 9% to 1,935,141 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 365d
  Director M33 Growth I L.P. sold $2,287,500 worth of shares (750,000 units at $3.05) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 369d
  Director Hively Brad exercised 1,867,605 shares at a strike of $0.90 and sold $5,672,106 worth of shares (1,976,137 units at $2.87), decreasing direct ownership by 15% to 603,501 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 382d
  Chief Clinical Officer Langsam Jeffrey was granted 57,380 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 382d
  Director M33 Growth I L.P. sold $5,425,800 worth of shares (2,000,000 units at $2.71) (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 383d
  Chief Executive Officer Virnich Daniel returned $54,538 worth of shares to the company (20,388 units at $2.67), decreasing direct ownership by 1% to 1,787,309 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 383d
  Chief Medical Officer Podnos Yale returned $4,818 worth of shares to the company (1,801 units at $2.67), decreasing direct ownership by 0.76% to 234,336 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 383d
  Chief Financial Officer Carter Robert Ross returned $4,283 worth of shares to the company (1,601 units at $2.67), decreasing direct ownership by 0.68% to 235,174 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 383d
  Chief Operating Officer Castle Jeremy returned $15,076 worth of shares to the company (5,636 units at $2.67), decreasing direct ownership by 2% to 247,031 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 433d
  Chief Medical Officer Podnos Yale was granted 157,088 shares, increasing direct ownership by 199% to 236,137 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 433d
  Chief Financial Officer Carter Robert Ross was granted 197,368 shares, increasing direct ownership by 501% to 236,775 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 433d
  Chief Operating Officer Castle Jeremy was granted 162,281 shares, increasing direct ownership by 180% to 252,667 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 433d
  Chief Executive Officer Virnich Daniel was granted 1,083,334 shares, increasing direct ownership by 150% to 1,807,697 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 437d
  Director M33 Growth I L.P. was granted 2,716,898 shares (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 446d
  Chief Executive Officer Virnich Daniel returned $9,122 worth of shares to the company (10,261 units at $0.89), decreasing direct ownership by 1% to 701,723 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)
• 446d
  Chief Medical Officer Podnos Yale returned $2,645 worth of shares to the company (2,975 units at $0.89), decreasing direct ownership by 4% to 69,993 units (SEC Form 4)

  4 - Oncology Institute, Inc. (0001799191) (Issuer)

Other TOI categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 3
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends